Innovation, Ema Milano – The positive interaction between public and private research institutions and with the dynamic economic sector creates a fertile ground for new ideas and innovation in Milan: 22% of Italy’s patents are registered in Milan while the city’s rate of 114 registered patents per million inhabitants is higher than that of London.
Some of the world’s leading achievements within the pharmaceutical industry were developed in the Milan area, such as the first gene therapy registered in Europe (Strimveli); the first stem-cell therapy in the world (Holocar) and the first genomic approach to vaccines, particularly with the development of the meningococcal B vaccine.
Moreover, Milan is a leader in Italy in the creation and development of start-ups. Polihub, the business incubator of the Milan Polytechnic University, was recently placed fifth on a ranking of 1,200 university business incubators drawn up by the Swedish research centre UBI Global. There are more than 1,500 innovative start-ups in the Milan area with an annual turnover of over €1,6bn in venture capital.